These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2258214)

  • 1. Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults.
    Zuberi SJ; Lodi TZ; Hassan R; Alam SE
    Indian J Gastroenterol; 1990 Oct; 9(4):291-2. PubMed ID: 2258214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant-yeast-derived hepatitis B vaccine in healthy adults: safety and two-year immunogenicity of early investigative lots of vaccine.
    Butterly L; Watkins E; Dienstag JL
    J Med Virol; 1989 Feb; 27(2):155-9. PubMed ID: 2522148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and tolerance of a yeast-derived hepatitis B vaccine in homosexual men.
    Prinsen H; Goilav C; Safary A; André FE; Piot P
    Postgrad Med J; 1987; 63 Suppl 2():147-9. PubMed ID: 3317352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of yeast-derived hepatitis B vaccines in young adults.
    Bergamini F; Zanetti A
    Postgrad Med J; 1987; 63 Suppl 2():137-8. PubMed ID: 3317349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B) in healthy young adults.
    Crovari P; Crovari PC; Petrilli RC; Icardi GC; Bonanni P
    Postgrad Med J; 1987; 63 Suppl 2():161-4. PubMed ID: 3317356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a recombinant hepatitis B vaccine in hemophiliacs.
    Mannucci PM; Gringeri A; Morfini M; De Biasi R; Tirindelli MC; Tamponi G; Baudo F; Carnelli V; Ciavarella N; Colombo M
    Am J Hematol; 1988 Dec; 29(4):211-4. PubMed ID: 3189317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore.
    Guan R; Tay HH; Yap I; Smith R; Tan LH
    Asian Pac J Allergy Immunol; 1989 Dec; 7(2):85-8. PubMed ID: 2533866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of recombinant yeast-derived hepatitis B vaccine in haemodialysis patients.
    Fujiyama S; Yoshida K; Sato T; Shimada H; Deguchi T
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():140-4. PubMed ID: 2150664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of low dose intradermally administered hepatitis B vaccine: a comparison of plasma-derived and recombinant yeast-derived vaccines.
    Söyletir G; Bahçeci E; Akoğlu E; Soyoğul U; Lawrance RA
    Vaccine; 1992; 10(5):301-4. PubMed ID: 1533478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
    Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
    Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactogenicity and immunogenicity of a new recombinant yeast-derived hepatitis B vaccine.
    Scheiermann N; Gesemann KM; Paar D; Maurer C
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 269(3):411-21. PubMed ID: 2975448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants.
    Panda SK; Ramesh R; Rao KV; Gupta A; Zuckerman AJ; Nayak NC
    J Med Virol; 1991 Dec; 35(4):297-302. PubMed ID: 1802958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year experience with a recombinant hepatitis B vaccine.
    Jilg W; Schmidt M; Deinhardt F
    Infection; 1989; 17(2):70-6. PubMed ID: 2714860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant DNA hepatitis B vaccine containing Pre-S components of the HBV coat protein--a preliminary study on immunogenicity.
    Yap I; Guan R; Chan SH
    Vaccine; 1992; 10(7):439-42. PubMed ID: 1535170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B virus vaccination for older adults.
    Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
    J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine.
    Heijtink RA; Kruining J; Bakker M; Schalm SW
    Antiviral Res; 1985; Suppl 1():273-9. PubMed ID: 2935079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of anti-HBs and protective efficacy after administration of hepatitis B vaccine.
    Yoshida K; Fujiyama S; Sato T
    J Gastroenterol Hepatol; 1990; 5(2):126-9. PubMed ID: 2151729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactogenicity and immunogenicity of a recombinant hepatitis B vaccine compared with a plasma-derived vaccine in young adults.
    Just M; Berger R; Just V
    Postgrad Med J; 1987; 63 Suppl 2():121-3. PubMed ID: 3317346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.